Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 24% ± 9% | |
epithelial cell | 6 studies | 31% ± 9% | |
goblet cell | 5 studies | 27% ± 7% | |
endothelial cell | 4 studies | 20% ± 3% | |
GABAergic neuron | 3 studies | 28% ± 8% | |
glutamatergic neuron | 3 studies | 35% ± 8% | |
basal cell | 3 studies | 36% ± 12% | |
astrocyte | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1648.51 | 180 / 180 | 100% | 65.97 | 430 / 430 |
prostate | 100% | 1531.93 | 245 / 245 | 100% | 58.91 | 502 / 502 |
esophagus | 100% | 2079.35 | 1443 / 1445 | 100% | 40.24 | 183 / 183 |
breast | 100% | 1554.09 | 459 / 459 | 100% | 88.89 | 1116 / 1118 |
intestine | 100% | 1873.28 | 966 / 966 | 100% | 54.99 | 526 / 527 |
pancreas | 100% | 1652.23 | 327 / 328 | 100% | 49.82 | 178 / 178 |
thymus | 100% | 1473.61 | 653 / 653 | 100% | 44.82 | 602 / 605 |
bladder | 100% | 1655.48 | 21 / 21 | 99% | 48.08 | 501 / 504 |
uterus | 100% | 1595.29 | 170 / 170 | 99% | 47.58 | 456 / 459 |
stomach | 100% | 1508.68 | 359 / 359 | 99% | 50.85 | 284 / 286 |
lung | 99% | 1273.23 | 575 / 578 | 100% | 52.54 | 1152 / 1155 |
kidney | 100% | 1194.03 | 89 / 89 | 98% | 38.93 | 883 / 901 |
brain | 98% | 804.16 | 2591 / 2642 | 99% | 24.79 | 698 / 705 |
adrenal gland | 99% | 1726.62 | 256 / 258 | 94% | 30.73 | 217 / 230 |
skin | 100% | 1805.59 | 1808 / 1809 | 93% | 29.77 | 439 / 472 |
liver | 97% | 650.16 | 219 / 226 | 89% | 24.36 | 362 / 406 |
adipose | 100% | 1361.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.96 | 29 / 29 |
spleen | 100% | 1446.57 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.63 | 1 / 1 |
blood vessel | 100% | 1430.04 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 919.43 | 786 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 39.80 | 44 / 45 |
heart | 95% | 713.66 | 821 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 22.25 | 76 / 80 |
peripheral blood | 73% | 891.22 | 678 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048194 | Biological process | Golgi vesicle budding |
GO_0050714 | Biological process | positive regulation of protein secretion |
GO_0140450 | Biological process | protein targeting to Golgi apparatus |
GO_0007030 | Biological process | Golgi organization |
GO_0006890 | Biological process | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
GO_0043001 | Biological process | Golgi to plasma membrane protein transport |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031985 | Cellular component | Golgi cisterna |
GO_0140312 | Molecular function | cargo adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
Gene name | GOLPH3L |
Protein name | Golgi phosphoprotein 3-like (GPP34-related protein) Golgi phosphoprotein 3 like |
Synonyms | GPP34R |
Description | FUNCTION: Phosphatidylinositol-4-phosphate-binding protein that may antagonize the action of GOLPH3 which is required for the process of vesicle budding at the Golgi and anterograde transport to the plasma membrane. . |
Accessions | Q9H4A5 ENST00000271732.8 [Q9H4A5-1] Q5T5I6 ENST00000427665.1 |